ImmunoGen, Inc.: cashflow_financing

Value{"amount": 437596000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"}
Period2023-01-01 – 2023-06-30
Statuscurrent
EntityImmunoGen, Inc.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001558370-23-012564 · Open the official SEC filing →
Retrieved: 2026-08-19T08:28:08.271109+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0000855654/cashflow-financing/2023-06-30 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/696f2703-2414-451f-8c9d-e31a6cfcbefb

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies